3,3'-diindolylmethane has been researched along with Osteosarcoma in 1 studies
3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
Excerpt | Relevance | Reference |
---|---|---|
"The effect of the natural product 3,3'-diindolylmethane (DIM) on cytosolic Ca(2+) concentrations ([Ca(2+)](i)) and viability in MG63 human osteosarcoma cells was explored." | 7.78 | 3,3'-Diindolylmethane alters Ca2+ homeostasis and viability in MG63 human osteosarcoma cells. ( Chang, HT; Chen, IS; Chou, CT; Ho, CM; Hsu, SS; Huang, JK; Jan, CR; Kuo, CC; Liao, WC; Lin, KL; Liu, SI; Lu, YC; Tsai, JY; Wang, JL, 2012) |
"The effect of the natural product 3,3'-diindolylmethane (DIM) on cytosolic Ca(2+) concentrations ([Ca(2+)](i)) and viability in MG63 human osteosarcoma cells was explored." | 3.78 | 3,3'-Diindolylmethane alters Ca2+ homeostasis and viability in MG63 human osteosarcoma cells. ( Chang, HT; Chen, IS; Chou, CT; Ho, CM; Hsu, SS; Huang, JK; Jan, CR; Kuo, CC; Liao, WC; Lin, KL; Liu, SI; Lu, YC; Tsai, JY; Wang, JL, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lu, YC | 1 |
Chen, IS | 1 |
Chou, CT | 1 |
Huang, JK | 1 |
Chang, HT | 1 |
Tsai, JY | 1 |
Hsu, SS | 1 |
Liao, WC | 1 |
Wang, JL | 1 |
Lin, KL | 1 |
Liu, SI | 1 |
Kuo, CC | 1 |
Ho, CM | 1 |
Jan, CR | 1 |
1 other study available for 3,3'-diindolylmethane and Osteosarcoma
Article | Year |
---|---|
3,3'-Diindolylmethane alters Ca2+ homeostasis and viability in MG63 human osteosarcoma cells.
Topics: Anticarcinogenic Agents; Apoptosis; Calcium; Calcium Channels; Cell Line, Tumor; Cell Survival; Dose | 2012 |